The Medical Advisor

Executive Summary: Ultra-Processed Foods and Your Health This article explains the health concerns associated with ultra-processed foods (UPFs) —industrial products that typically contain many ingredients, additives, preservatives, artificial flavors, and colors and are designed for convenience, long shelf life, and palatability. It outlines evidence linking high consumption of these foods with widespread negative health outcomes and urges greater awareness of what we eat. Definition and Classification UPFs fall under the highest category (Group 4) in the NOVA food classification system, distinguishing them from unprocessed and minimally processed foods like fruits, vegetables, whole grains, and fresh meat. Major Health Risks Research shows that diets high in ultra-processed foods are associated with poorer health outcomes across multiple bodily systems . A broad umbrella review found consistent links between UPF intake and 32 different adverse health effects, including meta...

Numerous doctors treating long COVID and COVID vaccine injuries now suggest fasting as a potential therapy for overall symptom improvement.  As of 2026, this idea has moved beyond theory: the first randomized controlled trial ( Bunker et al., Scientific Reports ) found that a weekly ~38-hour fast added to daily time-restricted eating cut Long COVID symptom scores by over 50% across 10 weeks — significantly more than time-restricted eating alone. The trial is small (58 patients) and unblinded, and roughly 9 in 10 participants had a symptom flare-up at some point, so this is promising early evidence, not a proven cure, and extended fasting is not appropriate for everyone. In February 2024, Drs. Paul Marik and Yusuf (JP) Saleeby — as well as Matthew T.J. Halma of the World Council for Health — published another related  key research paper  in the peer-reviewed journal  Endocrine and Metabolic Science . Those of you who are familiar with Dr Paul Marik’s work over the pas...

By Dr. Frank Yap, MD · One Day Media Network · Published April 2026 · Last updated: November 9, 2026 · Medically reviewed by Dr. Frank Yap, MD · Educational content, not individual medical advice. U.S. FDA indications are used; brands, approvals, dosing and supply differ by country. Quick Answer Ozempic and Wegovy are the same molecule (semaglutide); Mounjaro is tirzepatide; Trulicity is dulaglutide. For weight loss, tirzepatide beat semaglutide 2.4 mg head-to-head (20.2% vs 13.7% at 72 weeks, SURMOUNT-5). Wegovy HD (semaglutide 7.2 mg, FDA-approved March 19, 2026) raised semaglutide's ceiling (18.7% in STEP UP) but has not been tested head-to-head against tirzepatide. For type 2 diabetes, tirzepatide lowered HbA1c more than semaglutide 1 mg (SURPASS-2), and since August 28, 2026 Mounjaro also carries a U.S. cardiovascular-risk-reduction indication (SURPASS-CVOT: noninferior to dulaglutide, HR 0...